All Stories

  1. Associations between Serum Insulin-Like Growth Factor-Related Molecules and Colorectal Cancer Risk by Tumor Location: A Nested Case-Control Study

    Article • Digestion, March 2025, Karger Publishers

    Dr Yasushi Sasaki

  2. Impact of Sensitive Circulating Tumor DNA Monitoring on CT Scan Intervals During Postoperative Colorectal Cancer Surveillance

    Article • Annals of Surgery Open, February 2025, Wolters Kluwer Health

    Dr Yasushi Sasaki

  3. Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit

    Article • Molecular & Cellular Proteomics, December 2024, Elsevier

    Dr Yasushi Sasaki

  4. Dynamic phospho-proteogenomic analysis of gastric cancer cells suggests host immunity provides survival benefit

    Article • February 2024, Cold Spring Harbor Laboratory Press

    Dr Yasushi Sasaki

  5. Association of serum superoxide dismutase activity and the incidence of colorectal cancer in a nested case-control study

    Article • Cancer Epidemiology, December 2023, Elsevier

    Dr Yasushi Sasaki

  6. Esophageal intraepithelial squamous cell neoplasia with epidermalization—A case with molecular analysis

    Article • Pathology International, June 2023, Wiley

    Dr Yasushi Sasaki

  7. Serum Soluble Fas Levels and Incidence of Liver Cancer in Nested Case–Control Study

    Article • Cancer Epidemiology Biomarkers & Prevention, December 2022, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  8. Impact of sensitive circulating tumor DNA monitoring on CT scan intervals during postoperative colorectal cancer surveillance

    Article • September 2022, Cold Spring Harbor Laboratory Press

    Masashi Idogawa, Dr Yasushi Sasaki

  9. Genomic analysis of an aggressive case with metastatic intrahepatic mucinous cholangiocarcinoma

    Article • Clinical Journal of Gastroenterology, June 2022, Springer Science + Business Media

    Dr Yasushi Sasaki

  10. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma

    Article • Cancer Medicine, March 2022, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  11. Mutation Analysis of Radioresistant Early-Stage Cervical Cancer

    Article • International Journal of Molecular Sciences, December 2021, MDPI AG

    Dr Yasushi Sasaki

  12. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes

    Article • Scientific Reports, October 2021, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  13. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer

    Article • Carcinogenesis, September 2021, Oxford University Press (OUP)

    Masashi Idogawa, Dr Yasushi Sasaki

  14. Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo

    Article • Nature Communications, June 2021, Springer Science + Business Media

    Dr Yasushi Sasaki

  15. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Masashi Idogawa, Dr Yasushi Sasaki

  16. Frequent Tumor Burden Monitoring of Esophageal Squamous Cell Carcinoma With Circulating Tumor DNA Using Individually Designed Digital Polymerase Chain Reaction

    Article • Gastroenterology, January 2021, Elsevier

    Dr Yasushi Sasaki

  17. Generation of functional liver tissue by establishing hepatobiliary connections ex vivo

    Article • November 2020, Springer Science + Business Media

    Dr Yasushi Sasaki

  18. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy

    Article • Gynecologic Oncology, November 2020, Elsevier

    Dr Yasushi Sasaki

  19. Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugs

    Article • PLOS One, September 2020, PLOS

    Dr Yasushi Sasaki

  20. Integrated genetic and epigenetic analysis of cancer‐related genes in non‐ampullary duodenal adenomas and intramucosal adenocarcinomas

    Article • The Journal of Pathology, September 2020, Wiley

    Dr Yasushi Sasaki

  21. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy

    Article • Medicine, August 2020, Wolters Kluwer Health

    Dr Yasushi Sasaki

  22. Circulating-tumor DNA from Two Types of Blood Collection Tubes for Monitoring Tumor Burden Validated with Esophageal Squamous Cell Carcinoma Patients

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Dr Yasushi Sasaki

  23. Combination of KRAS and SMAD4 mutations in formalin‐fixed paraffin‐embedded tissues as a biomarker for pancreatic cancer

    Article • Cancer Science, May 2020, Wiley

    Dr Yasushi Sasaki

  24. Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCR

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Dr Yasushi Sasaki

  25. Genetic analyses of mosaic neurofibromatosis type 1 with giant café‐au‐lait macule, plexiform neurofibroma and multiple melanocytic nevi

    Article • The Journal of Dermatology, April 2020, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  26. Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients

    Article • Oral Oncology, March 2020, Elsevier

    Dr Yasushi Sasaki

  27. Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum

    Article • PLOS One, February 2020, PLOS

    Dr Yasushi Sasaki

  28. Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH)

    Article • Cancer Biology & Therapy, December 2019, Taylor & Francis

    Masashi Idogawa, Dr Yasushi Sasaki

  29. p53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53

    Article • Oncogene, December 2019, Springer Science + Business Media

    Dr Yasushi Sasaki, Masashi Idogawa

  30. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis

    Article • Cancer Science, December 2019, Wiley

    Dr Yasushi Sasaki

  31. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy

    Article • International Journal of Molecular Sciences, September 2019, MDPI AG

    Dr Yasushi Sasaki

  32. Corrigendum to “Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer”

    Article • Journal of Oncology, August 2019, Hindawi Publishing Corporation

    Masashi Idogawa, Dr Yasushi Sasaki

  33. Genomic characterization for familial cases with urothelial carcinoma

    Article • International Cancer Conference Journal, June 2019, Springer Science + Business Media

    Dr Yasushi Sasaki

  34. Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer

    Article • Journal of Oncology, May 2019, Hindawi Publishing Corporation

    Dr Yasushi Sasaki, Masashi Idogawa

  35. A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors

    Article • Journal of Experimental & Clinical Cancer Research, March 2019, Springer Science + Business Media

    Dr Yasushi Sasaki, Dr Mikito Inokuchi

  36. Malignant paraganglioma of the posterior mediastinum: A case report with genetic analysis

    Article • Molecular and Clinical Oncology, November 2018, Spandidos Publications

    Dr Yasushi Sasaki

  37. Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment

    Article • Cancer Letters, October 2018, Elsevier

    Dr Yasushi Sasaki

  38. DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling

    Article • Haematologica, August 2018, Ferrata Storti Foundation (Haematologica)

    Dr Yasushi Sasaki

  39. Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy

    Article • Oncotarget, August 2018, Impact Journals, LLC

    Dr Yasushi Sasaki

  40. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma

    Article • Tumor Biology, August 2018, SAGE Publications

    Dr Yasushi Sasaki, Masashi Idogawa

  41. Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1

    Article • Cell Death and Disease, August 2018, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  42. Prognostic nutritional index and early mortality with percutaneous endoscopic gastrostomy

    Article • QJM, June 2018, Oxford University Press (OUP)

    Dr Yasushi Sasaki

  43. Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors

    Article • Journal of Gastroenterology, June 2018, Springer Science + Business Media

    Dr Yasushi Sasaki

  44. Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma

    Article • Oncotarget, May 2018, Impact Journals, LLC

    Dr Yasushi Sasaki

  45. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis

    Article • February 2018, Springer Science + Business Media

    Dr Yasushi Sasaki

  46. Targeted sequencing reveals genetic variants associated with sensitivity of 79 human cancer xenografts to anticancer drugs

    Article • Experimental and Therapeutic Medicine, November 2017, Spandidos Publications

    Dr Yasushi Sasaki

  47. Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53

    Article • Cancer Science, November 2017, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  48. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing

    Article • Oncotarget, July 2017, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  49. Fledglings in p53 signaling network

    Article • Oncotarget, July 2017, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  50. Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation

    Article • PLOS One, May 2017, PLOS

    Dr Yasushi Sasaki

  51. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN

    Article • Cancer Letters, April 2017, Elsevier

    Masashi Idogawa, Dr Yasushi Sasaki

  52. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function

    Article • International Journal of Cancer, March 2017, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  53. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells

    Article • PLOS One, December 2016, PLOS

    Dr Yasushi Sasaki

  54. Systemic Prophylactic Antibiotics for the Modified Introducer Method for Percutaneous Endoscopic Gastrostomy

    Article • Journal of Clinical Gastroenterology, October 2016, Wolters Kluwer Health

    Dr Yasushi Sasaki

  55. Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target

    Article • Oncotarget, August 2016, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  56. Plasticity of lung cancer stem-like cells is regulated by the transcription factor HOXA5 that is induced by oxidative stress

    Article • Oncotarget, July 2016, Impact Journals, LLC

    Dr Yasushi Sasaki

  57. The effect of forced expression of mutatedK-RASgene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy

    Article • Molecular Carcinogenesis, June 2016, Wiley

    Dr Yasushi Sasaki

  58. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing

    Article • World Journal of Gastroenterology, February 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Yasushi Sasaki

  59. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors

    Article • Oncotarget, October 2015, Impact Journals, LLC

    Dr Yasushi Sasaki

  60. Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing

    Article • OncoTargets and Therapy, October 2015, Dove Medical Press

    Dr Yasushi Sasaki

  61. CRKL oncogene is downregulated by p53 through miR‐200s

    Article • Cancer Science, July 2015, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  62. Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells

    Article • Oncotarget, July 2014, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  63. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions

    Article • International Journal of Cancer, April 2014, Wiley

    Dr Yasushi Sasaki

  64. Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites

    Article • Human Molecular Genetics, January 2014, Oxford University Press (OUP)

    Masashi Idogawa, Dr Yasushi Sasaki

  65. Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness

    Article • Oncogene, November 2013, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  66. AKR1B10, a Transcriptional Target of p53, Is Downregulated in Colorectal Cancers Associated with Poor Prognosis

    Article • Molecular Cancer Research, October 2013, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  67. The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma

    Article • Tumor Biology, September 2013, Springer Science + Business Media

    Dr Yasushi Sasaki

  68. CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion

    Article • Cancer Biology & Therapy, December 2012, Taylor & Francis

    Masashi Idogawa, Dr Yasushi Sasaki

  69. Molecular Dissection of Premalignant Colorectal Lesions Reveals Early Onset of the CpG Island Methylator Phenotype

    Article • American Journal Of Pathology, November 2012, Elsevier

    Dr Yasushi Sasaki

  70. A novel approach to cancer treatment using structural hybrids of the p53 gene family

    Article • Cancer Gene Therapy, September 2012, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  71. Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes

    Article • Cell Stress and Chaperones, July 2012, Springer Science + Business Media

    Dr Yasushi Sasaki

  72. CHFR Protein Regulates Mitotic Checkpoint by Targeting PARP-1 Protein for Ubiquitination and Degradation

    Article • Journal of Biological Chemistry, February 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Masashi Idogawa, Dr Yasushi Sasaki

  73. p53 Negatively Regulates the Hepatoma Growth Factor HDGF

    Article • Cancer Research, October 2011, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  74. Genome-wide Profiling of Chromatin Signatures Reveals Epigenetic Regulation of MicroRNA Genes in Colorectal Cancer

    Article • Cancer Research, July 2011, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  75. Epigenetic Alteration of DNA in Mucosal Wash Fluid Predicts Invasiveness of Colorectal Tumors

    Article • Cancer Prevention Research, May 2011, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  76. Identification and characterization of early growth response 2, a zinc-finger transcription factor, as a p53-regulated proapoptotic gene

    Article • International Journal of Oncology, October 2010, Spandidos Publications

    Dr Yasushi Sasaki

  77. Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat

    Article • Journal of Gastroenterology, September 2010, Springer Science + Business Media

    Dr Yasushi Sasaki

  78. DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae

    Article • Cancer Science, April 2010, Wiley

    Dr Yasushi Sasaki

  79. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer

    Article • Breast Cancer Research and Treatment, October 2009, Springer Science + Business Media

    Dr Yasushi Sasaki

  80. N-Propionyl-Cysteaminylphenol-Magnetite Conjugate (NPrCAP/M) Is a Nanoparticle for the Targeted Growth Suppression of Melanoma Cells

    Article • Journal of Investigative Dermatology, September 2009, Elsevier

    Dr Yasushi Sasaki

  81. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype

    Article • Carcinogenesis, July 2009, Oxford University Press (OUP)

    Dr Yasushi Sasaki

  82. Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity

    Article • The Journal of Pathology, July 2009, Wiley

    Dr Yasushi Sasaki

  83. A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth

    Article • BMC Cancer, June 2009, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  84. Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma

    Article • Clinical Cancer Research, June 2009, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  85. A Single Recombinant Adenovirus Expressing p53 and p21-targeting Artificial microRNAs Efficiently Induces Apoptosis in Human Cancer Cells

    Article • Clinical Cancer Research, May 2009, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  86. CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-κB

    Article • Oncogene, May 2009, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  87. p53 Family Members Regulate the Expression of the Apolipoprotein D Gene

    Article • Journal of Biological Chemistry, November 2008, American Society for Biochemistry & Molecular Biology (ASBMB)

    Masashi Idogawa, Dr Yasushi Sasaki

  88. LINE-1 Hypomethylation Is Associated with Increased CpG Island Methylation in Helicobacter pylori-Related Enlarged-Fold Gastritis

    Article • Cancer Epidemiology Biomarkers & Prevention, October 2008, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  89. Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer

    Article • Cancer Research, June 2008, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  90. Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma

    Article • Cancer Science, May 2008, Wiley

    Dr Yasushi Sasaki

  91. In vitro transformation of adult rat hepatic progenitor cells into pancreatic endocrine hormone-producing cells

    Article • Journal of Hepato-Biliary-Pancreatic Surgery, May 2008, Springer Science + Business Media

    Dr Yasushi Sasaki

  92. Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models

    Article • Molecular Cancer Therapeutics, April 2008, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  93. Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer

    Article • Carcinogenesis, February 2008, Oxford University Press (OUP)

    Dr Yasushi Sasaki

  94. Identification of Flotillin-2, a Major Protein on Lipid Rafts, as a Novel Target of p53 Family Members

    Article • Molecular Cancer Research, February 2008, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  95. Gene Amplification and Overexpression of PRDM14 in Breast Cancers

    Article • Cancer Research, October 2007, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  96. PRDM5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer

    Article • Clinical Cancer Research, August 2007, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  97. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors

    Article • Carcinogenesis, August 2007, Oxford University Press (OUP)

    Masashi Idogawa, Dr Yasushi Sasaki

  98. Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines

    Article • Cancer Biology & Therapy, July 2007, Taylor & Francis

    Masashi Idogawa, Dr Yasushi Sasaki

  99. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer

    Article • Oncogene, February 2007, Springer Science + Business Media

    Dr Yasushi Sasaki

  100. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer

    Article • Cancer Science, January 2007, Wiley

    Dr Yasushi Sasaki

  101. Activation of the ribosomal protein L13 gene in human gastrointestinal cancer

    Article • International Journal of Molecular Medicine, July 2006, Spandidos Publications

    Dr Yasushi Sasaki

  102. Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation

    Article • Cancer Research, May 2006, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  103. The role of T-fimbrin in the response to DNA damage: Silencing of T-fimbrin by small interfering RNA sensitizes human liver cancer cells to DNA-damaging agents

    Article • International Journal of Oncology, October 2005, Spandidos Publications

    Dr Yasushi Sasaki

  104. Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors

    Article • Cancer Biology & Therapy, July 2005, Taylor & Francis

    Dr Yasushi Sasaki

  105. The Ras Effector RASSF2 Is a Novel Tumor-Suppressor Gene in Human Colorectal Cancer

    Article • Gastroenterology, July 2005, Elsevier

    Dr Yasushi Sasaki

  106. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes

    Article • Oncogene, April 2005, Springer Science + Business Media

    Dr Yasushi Sasaki

  107. Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours

    Article • British Journal of Cancer, March 2005, Springer Science + Business Media

    Dr Yasushi Sasaki

  108. Abnormal β-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features

    Article • Human Pathology, March 2005, Elsevier

    Dr Yasushi Sasaki

  109. Aberrant Methylation and Silencing of theBNIP3Gene in Colorectal and Gastric Cancer

    Article • Clinical Cancer Research, February 2005, American Association for Cancer Research (AACR)

    Dr Yasushi Sasaki

  110. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells

    Article • Oncogene, October 2004, Springer Science + Business Media

    Dr Yasushi Sasaki

  111. Identification of SCN3B as a novel p53-inducible proapoptotic gene

    Article • Oncogene, August 2004, Springer Science + Business Media

    Dr Yasushi Sasaki

  112. Aberrant Methylation and Histone Deacetylation Associated with Silencing of SLC5A8 in Gastric Cancer

    Article • Tumor Biology, January 2004, Springer Science + Business Media

    Dr Yasushi Sasaki

  113. Ichikawa et al., ?Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer?.Int J Cancer 2004; 112:967-973

    Article • International Journal of Cancer, January 2004, Wiley

    Dr Yasushi Sasaki

  114. Epigenetic inactivation of CHFR in human tumors

    Article • Proceedings of the National Academy of Sciences, June 2003, Proceedings of the National Academy of Sciences

    Dr Yasushi Sasaki

  115. Analysis of lung tumorigenesis in chimeric mice indicates the Pulmonary adenoma resistance 2 (Par2) locus to operate in the tumor-initiation stage in a cell-autonomous manner: detection of polymorphisms in the Polı gene as a candidate for Par2

    Article • Oncogene, April 2003, Springer Science + Business Media

    Dr Yasushi Sasaki

  116. Interleukin‐4‐expressing plasmid DNA inhibits reovirus type‐2‐triggered autoimmune insulitis in DBA/1 J suckling mice

    Article • International Journal of Experimental Pathology, April 2003, Wiley

    Dr Yasushi Sasaki

  117. Induction of tenascin-C by tumor-specificEWS-ETS fusion genes

    Article • Genes Chromosomes and Cancer, January 2003, Wiley

    Dr Yasushi Sasaki

  118. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors

    Article • Oncogene, November 2002, Springer Science + Business Media

    Dr Yasushi Sasaki

  119. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers

    Article • British Journal of Cancer, June 2002, Springer Science + Business Media

    Dr Yasushi Sasaki

  120. Identification of theOsteopontin gene as a direct target of TP53

    Article • Genes Chromosomes and Cancer, January 2002, Wiley

    Dr Yasushi Sasaki

  121. Increased expression of T-fimbrin gene after DNA damage in CHO cells and inactivation of T-fimbrin by CpG methylation in human colorectal cancer cells

    Article • International Journal of Cancer, December 2001, Wiley

    Dr Yasushi Sasaki

  122. Thep53Family Member Genes Are Involved in the Notch Signal Pathway

    Article • Journal of Biological Chemistry, October 2001, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Yasushi Sasaki

  123. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer

    Article • Gene Therapy, September 2001, Springer Science + Business Media

    Dr Yasushi Sasaki

  124. Jejunal carcinoid tumor mimicking leiomyosarcoma: preoperative diagnosis by endoscopic biopsy

    Article • Journal of Gastroenterology, January 2001, Springer Science + Business Media

    Dr Yasushi Sasaki

  125. Mutational Analysis of the β-Catenin Gene in Gastric Carcinomas

    Article • Tumor Biology, January 2001, Springer Science + Business Media

    Dr Yasushi Sasaki

  126. Identification of genes highly expressed in G2-arrested Chinese hamster ovary cells by differential display analysis

    Article • Journal of Clinical Laboratory Analysis, January 2000, Wiley

    Dr Yasushi Sasaki

  127. Involvement of cyclooxygenase-2 in proliferation and morphogenesis induced by transforming growth factor α in gastric epithelial cells

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, November 1999, Elsevier

    Dr Yasushi Sasaki

  128. Subcapsular hematoma of the liver and pylethrombosis in the setting of cholestatic liver injury

    Article • Journal of Gastroenterology, November 1996, Springer Science + Business Media

    Dr Yasushi Sasaki

  129. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma

    Article • International Journal of Oncology, June 1992, Spandidos Publications

    Dr Yasushi Sasaki